StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
ArcticZymes Technologies ASA
Oslo Stock Exchange:AZT.OL
Sector
Industries
Location
Market Cap
USD 87.53 M
Share Price
USD 1.63
Avg Daily Volume
23,705
Change (1 day)
1.95%
Change (1 year)
-23.42%
Change (YTD)
38.86%
ArcticZymes Technologies ASA Operating Cash Flow for the year ending December 31, 2024: USD 145.69 K
ArcticZymes Technologies ASA Operating Cash Flow is USD 145.69 K for the year ending December 31, 2024, a -93.93% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
ArcticZymes Technologies ASA Operating Cash Flow for the year ending December 31, 2023 was USD 2.40 M, a -59.50% change year over year.
-
ArcticZymes Technologies ASA Operating Cash Flow for the year ending December 31, 2022 was USD 5.92 M, a -30.25% change year over year.
-
ArcticZymes Technologies ASA Operating Cash Flow for the year ending December 31, 2021 was USD 8.49 M, a 55.26% change year over year.
-
ArcticZymes Technologies ASA Operating Cash Flow for the year ending December 31, 2020 was USD 5.47 M, a 1,111.31% change year over year.
Competitors
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Novo Nordisk A/S
USD 71.29
NOVO-B.CO
+1.87
2.69%
Roche Holding AG
USD 349.07
RO.SW
+1.94
0.56%
Novartis AG
USD 124.22
NOVN.SW
+1.53
1.24%
Abbott Laboratories
USD 133.60
ABT
+0.38
0.29%
AstraZeneca PLC
USD 144.13
AZN.L
+3.37
2.39%
Merck & Co., Inc.
USD 84.02
MRK
+0.31
0.37%
Thermo Fisher Scientific Inc.
USD 430.73
TMO
+10.85
2.58%
Amgen Inc.
USD 300.37
AMGN
+3.85
1.30%
Boston Scientific Corporation
USD 103.86
BSX
+0.90
0.87%
Pfizer Inc.
USD 25.78
PFE
+0.22
0.86%
Danaher Corporation
USD 205.51
DHR
+4.55
2.26%
Gilead Sciences, Inc.
USD 114.54
GILD
+1.30
1.15%
Vertex Pharmaceuticals Incorporated
USD 479.53
VRTX
+0.56
0.12%
Sanofi
USD 98.46
SAN.PA
+0.82
0.84%
Bristol-Myers Squibb Company
USD 48.52
BMY
+0.86
1.80%
GSK plc
USD 19.73
GSK.L
+0.37
1.92%
Chugai Pharmaceutical Co., Ltd.
USD 46.66
4519.T
-0.22
-0.47%
CSL Limited
USD 159.67
CSL.AX
+0.42
0.26%
Zoetis Inc.
USD 158.80
ZTS
+0.53
0.34%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Novo Nordisk A/S
USD 71.29
NOVO-B.CO
+1.87
2.69%
Roche Holding AG
USD 349.07
RO.SW
+1.94
0.56%
Novartis AG
USD 124.22
NOVN.SW
+1.53
1.24%
Abbott Laboratories
USD 133.60
ABT
+0.38
0.29%
AstraZeneca PLC
USD 144.13
AZN.L
+3.37
2.39%
Merck & Co., Inc.
USD 84.02
MRK
+0.31
0.37%
Thermo Fisher Scientific Inc.
USD 430.73
TMO
+10.85
2.58%
Amgen Inc.
USD 300.37
AMGN
+3.85
1.30%
Boston Scientific Corporation
USD 103.86
BSX
+0.90
0.87%
Pfizer Inc.
USD 25.78
PFE
+0.22
0.86%
Danaher Corporation
USD 205.51
DHR
+4.55
2.26%
Gilead Sciences, Inc.
USD 114.54
GILD
+1.30
1.15%
Vertex Pharmaceuticals Incorporated
USD 479.53
VRTX
+0.56
0.12%
Sanofi
USD 98.46
SAN.PA
+0.82
0.84%
Bristol-Myers Squibb Company
USD 48.52
BMY
+0.86
1.80%
GSK plc
USD 19.73
GSK.L
+0.37
1.92%
Chugai Pharmaceutical Co., Ltd.
USD 46.66
4519.T
-0.22
-0.47%
CSL Limited
USD 159.67
CSL.AX
+0.42
0.26%
Zoetis Inc.
USD 158.80
ZTS
+0.53
0.34%